Top compounds associated with response to ADORA2B


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.064 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.0074 0.9
mRNA tivozanib CTRPv2 pan-cancer AAC 0.00054 1
mRNA tosedostat CTRPv2 pan-cancer AAC -0.049 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.025 0.4
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.1 0.01
mRNA triptolide CTRPv2 pan-cancer AAC 0.015 0.7
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.15 0.008
Download CSV